Janssen Robert 4/A
4/A · DYNAVAX TECHNOLOGIES CORP · Filed Feb 7, 2024
Insider Transaction Report
Form 4/AAmended
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Common Stock
2024-02-03+10,000→ 59,925 total - Tax Payment
Common Stock
2024-02-05$12.79/sh−4,043$51,710→ 55,882 total - Exercise/Conversion
Restricted Stock Unit
2024-02-03−10,000→ 0 total→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Code M: Exercise or conversion of derivative security
- [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 3, 2021.
- [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
- [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.